Who are LENZ Therapeutics, Inc.'s main suppliers?

LENZ Therapeutics, Inc. (LENZ) key suppliers include: Alvotech, Alvotech, Johnson & Johnson, Johnson & Johnson. View the full supplier network at chainsifter.com/chain/LENZ.

Who are LENZ Therapeutics, Inc.'s major customers?

LENZ Therapeutics, Inc. (LENZ) key customers include: LUNATUS, WHOLESALER-CUSTOMERS, Alvotech, Alvotech, Johnson & Johnson and 1 more. View the full customer network at chainsifter.com/chain/LENZ.

What sector is LENZ Therapeutics, Inc. in?

LENZ Therapeutics, Inc. (LENZ) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

LENZ Supply Chain: LENZ Therapeutics, Inc. Supplier List & 13 Relationships

4Suppliers

6Customers

3Debt Items

20Related Chains

LENZ Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ALVO	Alvotech	72%	Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization of innovative therapies to improve vision. On July 31, 2025, the United States (“…
ALVO	Alvotech	72%	Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization…
JNJ	Johnson & Johnson	72%	Good Manufacturing Practices (“cGMP”) regulatory guidelines. A Drug Master File (“DMF”) is on file with the FDA for the API. Commercial supply agreements have been secured with our API suppliers with…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from LENZ graph: Good Manufacturing Practices (“cGMP”) regulatory guidelines. A Drug Master File (“DMF”) is on file with the FDA for th…

LENZ Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
LUNATUS	LUNATUS	92%	In January 2026, LENZ announced an exclusive commercialization partnership with Lunatus for the Middle East.
WHOLESALER-CUSTOMERS	WHOLESALER-CUSTOMERS	92%	For the three months ended March 31, 2026, the Company's three wholesaler customers each individually accounted for more than 10% of total product sales.
ALVO	Alvotech	72%	Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization of innovative therapies to improve vision. On July 31, 2025, the United States (“…
ALVO	Alvotech	72%	Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Item 1. Business Overview We are a …
JNJ	Johnson & Johnson	72%	y as described in “Consumer Sampling Strategy”. To meet the long-term usage needs of young and old presbyopes, we plan to offer both retail access and collaborate with e-pharmacy vendors to provide e…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from LENZ graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from LENZ graph: y as described in “Consumer Sampling …

LENZ Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LENZ-DEBT-10654	Warrants outstanding: 1918000	90%	xbrl warrant detail from xbrl 2025-12-31.
LENZ-DEBT-10655	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
LENZ-DEBT	Debt stack $673,000	90%	Market cache reports total debt of $673,000.

LENZ Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LENZ Therapeutics, Inc..

LENZ Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
LENZ-OWNER-RA-CAPITAL-MANAGEMENT-L-P	RA CAPITAL MANAGEMENT, L.P.	90%	13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 148 tracked holders.

LENZ Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ADGM	Adagio Medical Holdings, Inc.	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
TRIB	Trinity Biotech plc	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
ACIU	AC Immune SA	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
ALVO	Alvotech	100.00	1	['customer', 'supplier']
BNRG	Brenmiller Energy Ltd	100.00	2
ABBV	AbbVie Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
AORT	Artivion, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2

LENZ Therapeutics, Inc. Supply Chain